Franciscan Health Lafayette East has had the privilege on being one of the first 3 centers in the United States to utilize the Quest MP3ND cardiopulmonary bypass systems. Dr. Hartmuth Bittner has performed 55 open heart surgeries to date with this new technology. The MP3ND was introduced in 2021 with advanced technology in addition to the features of the traditional MPS2. This system allows more versatility and precision with each patient, allowing us to deliver a more controlled arrest and confident myocardial protection. We have the ability to deliver all blood microplegia at any ratio as well as Custodial crystalloid cardioplegia, also known as Histidine-Tryptophan-Ketoglutarate solution. The Quest MP3ND allows us to adjust the drug delivery to exact dosing allowing cardioplegia delivery to be patient specific. The MPS3 ND superior advanced technology with touch screen active monitoring controller and numerous additional safety features. The real time data collection and internal battery are new features for cardioplegia delivery systems. The auto start feature allows for precise closure of the patients aortic valve and better distribution of cardioplegia. Once arrested, we can select the auto feature to continue to deliver our cardioplegia solution with variable flow at a precise pressure while delivering antegrade, ostial, or retrograde cardioplegia. The additional ND feature, no disinfection, mitigates the risk of M.Chimera contamination. The MPS3ND disposable attaches externally to a water source to thermoregulate the patient’s cardioplegia circuit for cold or warm delivery. With the disconnection of this disposable, the system allows for complete removal of water from the MPS system after the case. This feature alleviates the risk of contaminating the cardiac OR sterile field, and therefore the costs associated with surgical site infections due to Mycobacterium Chimera.
from WordPress https://ift.tt/3jodpm3
via IFTTT
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.